适应性交叉试验的样本大小的确定,用于检测基因药物相互作用
1Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois Chicago, Chicago, IL, USA.
Statistical methods in medical research
|July 11, 2023
概括
我们开发了一种新方法来计算适应交叉试验的样本大小,提高药物基因相互作用研究的统计能力. 这种方法确保了对诸如心房动等治疗方法的可靠研究结果.
科学领域:
- 药物基因组学 药物基因组学
- 临床试验设计 临床试验设计
- 生物统计学 生物统计学
背景情况:
- 药物基因相互作用研究中平行和交叉设计是常见的.
- 适应交叉设计为患者提供选择,但使样本大小计算复杂化.
- 伦理考虑和统计能力是试验设计的关键因素.
研究的目的:
- 提出一种方法来确定适应性交叉试验中的样本大小.
- 为准确的样本大小计算提供封闭式公式.
- 将该方法应用于对心房的基因药物相互作用研究.
主要方法:
- 开发一个封闭式公式来确定样本大小.
- 该方法应用于适应性交叉试验场景.
- 模拟研究以确认拟议方法的统计能力.
主要成果:
- 成功开发了一种计算所需样本大小的新方法.
- 拟议的方法在模拟中实现了预先规定的统计能力.
- 该方法适用于基因药物相互作用的适应性交叉试验.
结论:
- 建议的封闭式公式有效地确定了适应性交叉试验的样本大小.
- 这种方法提高了统计能力,并解决了患者选择设计的复杂性.
- 提供了适应性交叉试验的实践指南,特别是对于心房的治疗.
相关概念视频
Crossover Experiments
2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K
Analysis of Population Pharmacokinetic Data
299
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
299
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K


